Lupin Gets TGA Nod, Faces US FDA Alerts

  Published 8 months ago

Lupin’s Dabhasa plant gets TGA GMP certification; Pithampur units receive FDA Form-483s with observations after inspections.

  • Dabhasa API facility certified by Australia’s TGA, enhancing Lupin’s global pharmaceutical manufacturing credibility.
  • Pithampur Unit-3 inspection ended with three observations; Unit-2 faced four, as per U.S. FDA Form-483s.
  • Lupin is committed to addressing issues, maintaining CGMP standards across facilities while expanding global contract manufacturing services.

You might like these

Jupiter Wagons CFO Steps Down

Kashmir Tourism Plummets After Violent Attacks

Indian Shares Mixed Amid U.S. Tariff Uncertainty, Consumer Stocks Rise

ITI Ltd. Reports Strong Revenue Growth & Reduced Losses

IndiGo Co-founder Sells $1.4B Stake

Indian Stocks See Foreign Investor Return

Atul Auto July Sales Up 11% YoY

News that matters the most ⚡